-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12

Benzinga·11/19/2025 12:15:58
Listen to the news
B. Riley Securities analyst Mayank Mamtani initiates coverage on Nuvation Bio (NYSE:NUVB) with a Buy rating and announces Price Target of $12.